Iwona Ziółkowska-Suchanek

Dr. Iwona Ziółkowska-Suchanek

Institute of Human Genetics, Polish Academy of Sciences
orcid

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 January 2021 in Cells
Verified
Journal Article
Open access
PDF file
IZIwona Ziółkowska-Suchanek
Iwona Ziółkowska-Suchanek
Hypoxia is the most common microenvironment feature of lung cancer tumors, which affects cancer progression, metastasis and metabolism. Oxygen induces both proteomic and genomic changes within tumor cells, which cause many alternations in the tumor microenvironment (TME). This review defines current knowledge in the field of tumor hypoxia in non-small cell lung cancer (NSCLC), including biology, biomarkers, in vitro and in vivo studies and also hypoxia imaging and detection. While classic two-dimensional (2D) in vitro research models reveal some hypoxia dependent manifestations, three-dimensional (3D) cell culture models more accurately replicate the hypoxic TME. In this study, a systematic review of the current NSCLC 3D models that have been able to mimic the hypoxic TME is presented. The multicellular tumor spheroid, organoids, scaffolds, microfluidic devices and 3D bioprinting currently being utilized in NSCLC hypoxia studies are reviewed. Additionally, the utilization of 3D in vitro models for exploring biological and therapeutic parameters in the future is described.

27 August 2015 in Scientific Reports
Verified
Journal Article
Open access
PDF file
IZIwona Ziółkowska-Suchanek
Iwona Ziółkowska-Suchanek
MMMaria Mosor
Maria Mosor
Piotr GabryelPiotr Gabryel
Piotr Gabryel
MGMarcin Grabicki
Marcin Grabicki
MŻMagdalena Żurawek
Magdalena Żurawek
JNJerzy Nowak
Jerzy Nowak
Genome-wide association studies have identified loci at 15q25 (IREB2) and 4q22 (FAM13A), associated with lung cancer (LC) and chronic obstructive pulmonary disease (COPD). The aim of our research was to determine the association of IREB2 and FAM13A SNPs with LC and severe/very severe COPD patients. We examined IREB2 variants (rs2568494, rs2656069, rs10851906, rs13180) and FAM13A (rs1903003, rs7671167, rs2869967) among 1.141 participants (468 LC, 149 COPD, 524 smoking controls). The frequency of the minor IREB2 rs2568494 AA genotype, was higher in LC vs controls (P = 0.0081, OR = 1.682). The FAM13A rs2869967 was associated with COPD (minor CC genotype: P = 0.0007, OR = 2.414). The rs1903003, rs7671167 FAM13A variants confer a protective effect on COPD (both P < 0.002, OR < 0.405). Haplotype-based tests identified an association of the IREB2 AAAT haplotype with LC (P = 0.0021, OR = 1.513) and FAM13A TTC with COPD (P = 0.0013, OR = 1.822). Cumulative genetic risk score analyses (CGRS), derived by adding risk alleles, revealed that the risk for COPD increased with the growing number of the FAM13A risk alleles. OR (95% CI) for carriers of ≥5 risk alleles reached 2.998 (1.8 to 4.97) compared to the controls. This study confirms that the IREB2 variants contribute to an increased risk of LC, whereas FAM13A predisposes to increased susceptibility to COPD.

1 August 2018 in Diabetes Research and Clinical Practice
Verified
Journal Article
Closed access
MŻMagdalena Żurawek
Magdalena Żurawek
ADAgnieszka Dzikiewicz-Krawczyk
Agnieszka Dzikiewicz-Krawczyk
Katarzyna IżykowskaKatarzyna Iżykowska
Katarzyna Iżykowska
IZIwona Ziółkowska-Suchanek
Iwona Ziółkowska-Suchanek
BSBogda Skowrońska
Bogda Skowrońska
JNJerzy Nowak
Jerzy Nowak

29 June 2006 in Leukemia
Verified
Journal Article
Open access
PDF file
MMM Mosor
M Mosor
IZIwona Ziółkowska-Suchanek
Iwona Ziółkowska-Suchanek
MPM Pernak-Schwarz
M Pernak-Schwarz
DJDanuta Januszkiewicz-Lewandowska
Danuta Januszkiewicz-Lewandowska
JNJ Nowak
J Nowak
Association of the heterozygous germline I171V mutation of the NBS1 gene with childhood acute lymphoblastic leukemia

18 February 2008 in European Journal of Cancer
Verified
Journal Article
Open access
PDF file
JNJerzy Nowak
Jerzy Nowak
MMMaria Mosor
Maria Mosor
IZIwona Ziółkowska-Suchanek
Iwona Ziółkowska-Suchanek
MWMałgorzata Wierzbicka
Małgorzata Wierzbicka
MPMonika Pernak-Schwarz
Monika Pernak-Schwarz
DJDanuta Januszkiewicz
Danuta Januszkiewicz
Homozygous mutation 657del5 within the NBS1 gene is responsible for the majority of Nijmegen breakage syndrome (NBS) cases. NBS patients are characterised by increased susceptibility to malignancies mainly of lymphoid origin. Recently it has been postulated that heterozygous carriers of 657del5 NBS1 mutation are at higher risk of cancer development. The aim of the study was to analyse the frequency of I171V mutation in NBS1 gene in 270 women with breast cancer, 176 patients with larynx cancer, 81 with second primary tumours of head and neck, 131 with colorectal carcinoma and 600 healthy individuals. I171V mutation was present in 17 cancer patients compared with only one in healthy individuals. This constitutes 2.58% in studied patients with malignancies and 0.17% in the control group (P=0.0002; relative risk 1.827; odds ratio 15.886; 95% confidence interval 2.107-119.8). Since DNA was isolated from non malignant cells, all mutations found in cancer patients appeared to be of germinal origin. It can be concluded that NBS1 allele I171V may be a general susceptibility gene in solid tumours.

1 November 2007 in Cancer Science
Verified
Journal Article
Closed access
PDF file
IZIwona Ziółkowska-Suchanek
Iwona Ziółkowska-Suchanek
MMMaria Mosor
Maria Mosor
MWMałgorzata Wierzbicka
Małgorzata Wierzbicka
MRMalgorzata Rydzanicz
Malgorzata Rydzanicz
MPMonika Pernak-Schwarz
Monika Pernak-Schwarz
JNJerzy Nowak
Jerzy Nowak